Literature DB >> 18388200

Reduced plasma high-density lipoprotein cholesterol in hyperthyroid mice coincides with decreased hepatic adenosine 5'-triphosphate-binding cassette transporter 1 expression.

Ivan Tancevski1, Andreas Wehinger, Egon Demetz, Philipp Eller, Kristina Duwensee, Julia Huber, Kathrin Hochegger, Wilfried Schgoer, Catherine Fievet, Frans Stellaard, Mats Rudling, Josef R Patsch, Andreas Ritsch.   

Abstract

The aim of the study was to investigate the influence of severe hyperthyroidism on plasma high-density lipoprotein cholesterol (HDL-C). Recently, it was shown in mice that increasing doses of T(3) up-regulate hepatic expression of scavenger receptor class B, type I, resulting in increased clearance of plasma HDL-C. Here, we show that severe hyperthyroidism in mice did not affect hepatic expression of scavenger receptor class B, type I, but reduced hepatic expression of ATP-binding cassette transporter 1, accompanied by a 40% reduction of HDL-C. The sterol content of bile, liver, and feces was markedly increased, accompanied by up-regulation of hepatic cholesterol 7alpha-hydroxylase, and ATP-binding cassette transporter 5, which is known to promote biliary sterol secretion upon dimerization with ATP-binding cassette transporter 8. Both control and hyperthyroid mice exerted identical plasma clearance of iv injected [(3)H]HDL-C, supporting the view that severe hyperthyroidism does not affect HDL-C clearance but, rather, its formation via hepatic ATP-binding cassette transporter 1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18388200      PMCID: PMC2993050          DOI: 10.1210/en.2007-1387

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  35 in total

Review 1.  Molecular regulation of HDL metabolism and function: implications for novel therapies.

Authors:  Daniel J Rader
Journal:  J Clin Invest       Date:  2006-12       Impact factor: 14.808

Review 2.  Emerging roles of the intestine in control of cholesterol metabolism.

Authors:  Janine-K Kruit; Albert K Groen; Theo J van Berkel; Folkert Kuipers
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

3.  Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population.

Authors:  T A Miettinen; R S Tilvis; Y A Kesäniemi
Journal:  Am J Epidemiol       Date:  1990-01       Impact factor: 4.897

4.  Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.

Authors:  Snehal U Naik; Xun Wang; Jaqueline S Da Silva; Michael Jaye; Colin H Macphee; Muredach P Reilly; Jeffrey T Billheimer; George H Rothblat; Daniel J Rader
Journal:  Circulation       Date:  2005-12-19       Impact factor: 29.690

5.  Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice.

Authors:  Lisen Johansson; Mats Rudling; Thomas S Scanlan; Thomas Lundåsen; Paul Webb; John Baxter; Bo Angelin; Paolo Parini
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

6.  Increased plasma levels of LDL cholesterol in rabbits after adenoviral overexpression of human scavenger receptor class B type I.

Authors:  Ivan Tancevski; Sasa Frank; Petra Massoner; Ursula Stanzl; Wilfried Schgoer; Andreas Wehinger; Catherine Fievet; Philipp Eller; Josef R Patsch; Andreas Ritsch
Journal:  J Mol Med (Berl)       Date:  2005-08-24       Impact factor: 4.599

7.  Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.

Authors:  Jenelle M Timmins; Ji-Young Lee; Elena Boudyguina; Kimberly D Kluckman; Liam R Brunham; Anny Mulya; Abraham K Gebre; Jonathan M Coutinho; Perry L Colvin; Thomas L Smith; Michael R Hayden; Nobuyo Maeda; John S Parks
Journal:  J Clin Invest       Date:  2005-04-07       Impact factor: 14.808

8.  Knockdown of hepatic ABCA1 by RNA interference decreases plasma HDL cholesterol levels and influences postprandial lipemia in mice.

Authors:  Sergei Ragozin; Andreas Niemeier; Alexander Laatsch; Britta Loeffler; Martin Merkel; Ulrike Beisiegel; Joerg Heeren
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-04-21       Impact factor: 8.311

9.  Sterol absorption and sterol balance in phytosterolemia evaluated by deuterium-labeled sterols: effect of sitostanol treatment.

Authors:  D Lütjohann; I Björkhem; U F Beil; K von Bergmann
Journal:  J Lipid Res       Date:  1995-08       Impact factor: 5.922

10.  Intestinal ABCA1 directly contributes to HDL biogenesis in vivo.

Authors:  Liam R Brunham; Janine K Kruit; Jahangir Iqbal; Catherine Fievet; Jenelle M Timmins; Terry D Pape; Bryan A Coburn; Nagat Bissada; Bart Staels; Albert K Groen; M Mahmood Hussain; John S Parks; Folkert Kuipers; Michael R Hayden
Journal:  J Clin Invest       Date:  2006-03-16       Impact factor: 14.808

View more
  8 in total

1.  The thyromimetic T-0681 protects from atherosclerosis.

Authors:  Ivan Tancevski; Andreas Wehinger; Egon Demetz; Julia Hoefer; Philipp Eller; Eva Huber; Ursula Stanzl; Kristina Duwensee; Kristina Auer; Wilfried Schgoer; Volker Kuhn; Catherine Fievet; Frans Stellaard; Mats Rudling; Bernhard Foeger; Josef R Patsch; Andreas Ritsch
Journal:  J Lipid Res       Date:  2008-12-22       Impact factor: 5.922

2.  The effect of obesity-related allostatic changes on cardio-metabolic risk in euthyroid children.

Authors:  A Tropeano; D Corica; S Curatola; A Li Pomi; C Casto; A Alibrandi; G Pepe; T Aversa; M Wasniewska
Journal:  J Endocrinol Invest       Date:  2022-08-20       Impact factor: 5.467

Review 3.  Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation.

Authors:  Yan-Yun Liu; Gregory A Brent
Journal:  Trends Endocrinol Metab       Date:  2009-12-16       Impact factor: 12.015

4.  Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease.

Authors:  Melpomeni Peppa; Grigoria Betsi; George Dimitriadis
Journal:  J Lipids       Date:  2011-07-18

5.  The liver-selective thyromimetic T-0681 influences reverse cholesterol transport and atherosclerosis development in mice.

Authors:  Ivan Tancevski; Egon Demetz; Philipp Eller; Kristina Duwensee; Julia Hoefer; Christiane Heim; Ursula Stanzl; Andreas Wehinger; Kristina Auer; Regina Karer; Julia Huber; Wilfried Schgoer; Miranda Van Eck; Jonathan Vanhoutte; Catherine Fievet; Frans Stellaard; Mats Rudling; Josef R Patsch; Andreas Ritsch
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

6.  Dyslipidemia and serum mineral profiles in patients with thyroid disorders.

Authors:  Abdelgayoum A Abdel-Gayoum
Journal:  Saudi Med J       Date:  2014-12       Impact factor: 1.484

7.  Ovarian cancer treatment with a tumor-targeting and gene expression-controllable lipoplex.

Authors:  Zhi-Yao He; Feng Deng; Xia-Wei Wei; Cui-Cui Ma; Min Luo; Ping Zhang; Ya-Xiong Sang; Xiao Liang; Li Liu; Han-Xiao Qin; Ya-Li Shen; Ting Liu; Yan-Tong Liu; Wei Wang; Yan-Jun Wen; Xia Zhao; Xiao-Ning Zhang; Zhi-Yong Qian; Yu-Quan Wei
Journal:  Sci Rep       Date:  2016-03-30       Impact factor: 4.379

8.  The role of free triiodothyronine in high-density lipoprotein cholesterol metabolism.

Authors:  Fang Huang; Lili Wu; Ye Qiu; Kunpeng Bu; Hui Huang; Bixun Li
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.